EBOS Group (EBO) AGM 2024 summary

Opening remarks and agenda

• Chair welcomed attendees in Auckland and online, outlined meeting format, and explained Q&A and voting procedures.

• Quorum was declared, directors and executives introduced, and the agenda was set: year highlights, financial review, and formal business with five resolutions.

• Chair Elizabeth Coutts and CEO John Cullity presented, followed by business items and meeting conclusion.

Financial performance review

• FY 2024 revenue reached $13.2 billion, up 7.8% year-on-year; underlying EBITDA grew 7.3% to $624.3 million.

• Net profit after tax rose 7.7% to $303.4 million; EPS increased 6.8% to 157.9 cents.

• Healthcare and animal care segments delivered strong organic and acquisition-driven growth.

• TerryWhite Chemmart network expanded to 600 stores; animal care EBITDA grew 13.2%.

• ROCE aligned with 15% target; cost management improved operating efficiency.

Board and executive committee updates

• Board renewal continued: Peter Williams retired, with Mark Bloom and Julie Tay appointed in the last two years.

• Matt Muscio elected as director effective January 2025; search for an additional non-executive Australian director ongoing.

• Chair signaled intention to retire after succession and knowledge transfer are complete.